Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes

Kalpaj Parekh, Sabarinathan Ramachandran, Joel Cooper, Darell Bigner, Alexander Patterson, T. Mohanakumar

Research output: Contribution to journalArticlepeer-review

60 Scopus citations


Purpose: Extracellular matrix (ECM) proteins play a significant role in the survival and metastasis of cancer cells. Tenascin-C (TN-C) is an extracellular matrix protein and its large isoform has been implicated in tumor progression. Goal of this study was to analyze the expression of the small and large isoforms of TN-C in non-small cell lung cancer (NSCLC) and determine its functional significance. Experimental design: TN-C expression was studied in tumor and non-tumor tissue of patients with NSCLC at the mRNA and protein level. Immunomodulatory properties of the large isoform of TN-C were analyzed by determining its effect on lymphocyte proliferation and cytokine secretion by tumor-infiltrating lymphocytes (TIL). Results: Quantitative real-time PCR analysis showed an eight-fold increase in the amount of large isoform in cancer cells compared to adjacent normal tissue. Expression at the protein level by Western blot analysis using a murine monoclonal anti-TN-C antibody detected increased expression of the large isoform in the tumor tissue that was correlated with the development of recurrent disease. A 18-fold increase in the expression of the large TN-C isoform was observed in patients with recurrent NSCLC compared to non-recurrent NSCLC. Large isoform of TN-C significantly inhibited anti-CD3 and mitogen-induced proliferation of human peripheral blood lymphocytes and interferon-gamma production by TIL isolated from the lung cancer specimens. Conclusions: Increased expression of TN-C observed at the site of tumor in NSCLC correlates with recurrence. TN-C inhibits TIL proliferation and cytokine thereby may promote tumor immune evasion and recurrence.

Original languageEnglish
Pages (from-to)17-29
Number of pages13
JournalLung Cancer
Issue number1
StatePublished - Jan 2005


  • Cellular immunity
  • Immunomodulation
  • Recurrence


Dive into the research topics of 'Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes'. Together they form a unique fingerprint.

Cite this